Lineage Cell Therapeutics (LCTX) EBIT (2010 - 2026)
Lineage Cell Therapeutics (LCTX) reported EBIT of -$7.6 million for Q1 2026, down 16.73% on a YoY basis from -$9.1 million in Q1 2025, and down 148.14% quarter-over-quarter from $15.8 million in Q4 2025.
Lineage Cell Therapeutics (LCTX) EBIT (2010 - 2026) Analysis & Trends
Lineage Cell Therapeutics has reported EBIT for 17 years, with the latest figure at -$7.6 million in Q1 2026.
- For the quarter ending Q1 2026, EBIT fell 16.73% year-over-year to -$7.6 million; the trailing twelve-month figure through Mar 2026 stood at -$15.4 million (up 27.84% YoY), and the FY2025 full-year result was -$14.3 million, up 33.43% from the prior year.
- EBIT for Q1 2026 stood at -$7.6 million, down from $15.8 million in the prior quarter.
- The five-year high for EBIT was $15.8 million in Q4 2025, with the low at -$19.8 million in Q2 2025.
- Historically, EBIT has averaged -$5.3 million across 5 years, with a median of -$6.4 million in 2023.
- The largest YoY upside for EBIT was 408.69% in 2025 against a maximum downside of 237.14% in 2025.
- Lineage Cell Therapeutics' EBIT stood at -$6.6 million in 2022, then increased by 4.17% to -$6.4 million in 2023, then climbed by 19.68% to -$5.1 million in 2024, then soared by 408.69% to $15.8 million in 2025, then slumped by 148.14% to -$7.6 million in 2026.
- The last three EBIT figures came in at -$7.6 million (Q1 2026), $15.8 million (Q4 2025), and -$3.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -32.68 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -15.76 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.51 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -65.83 Mn |
| 10 | Lineage Cell Therapeutics | 303.84 Mn | 239.94 Mn | 1.73 Mn | -7.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.59 Mn |
| Dec 31, 2025 | 15.77 Mn |
| Sep 30, 2025 | -3.79 Mn |
| Jun 30, 2025 | -19.78 Mn |
| Mar 31, 2025 | -6.51 Mn |
| Dec 31, 2024 | -5.11 Mn |
| Sep 30, 2024 | -3.84 Mn |
| Jun 30, 2024 | -5.87 Mn |
| Mar 31, 2024 | -6.66 Mn |
| Dec 31, 2023 | -6.36 Mn |
| Sep 30, 2023 | -6.71 Mn |
| Jun 30, 2023 | -5.02 Mn |
| Mar 31, 2023 | -6.64 Mn |
| Dec 31, 2022 | -6.64 Mn |
| Sep 30, 2022 | -5.25 Mn |
| Jun 30, 2022 | -4.23 Mn |
| Mar 31, 2022 | -6.40 Mn |
| Dec 31, 2021 | -28.24 Mn |
| Sep 30, 2021 | -6.84 Mn |
| Jun 30, 2021 | -7.08 Mn |